These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 11202131)

  • 1. Benefits from mianserin augmentation of fluoxetine in patients with major depression non-responders to fluoxetine alone.
    Ferreri M; Lavergne F; Berlin I; Payan C; Puech AJ
    Acta Psychiatr Scand; 2001 Jan; 103(1):66-72. PubMed ID: 11202131
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the effects of mirtazapine and fluoxetine in severely depressed patients.
    Versiani M; Moreno R; Ramakers-van Moorsel CJ; Schutte AJ;
    CNS Drugs; 2005; 19(2):137-46. PubMed ID: 15697327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination of antidepressant medications from treatment initiation for major depressive disorder: a double-blind randomized study.
    Blier P; Ward HE; Tremblay P; Laberge L; Hébert C; Bergeron R
    Am J Psychiatry; 2010 Mar; 167(3):281-8. PubMed ID: 20008946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Morning fluoxetine plus evening mianserin versus morning fluoxetine plus evening placebo in the acute treatment of major depression.
    Dam J; Ryde L; Svejsø J; Lauge N; Lauritsen B; Bech P
    Pharmacopsychiatry; 1998 Mar; 31(2):48-54. PubMed ID: 9562208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Double-blind study of high-dose fluoxetine versus lithium or desipramine augmentation of fluoxetine in partial responders and nonresponders to fluoxetine.
    Fava M; Alpert J; Nierenberg A; Lagomasino I; Sonawalla S; Tedlow J; Worthington J; Baer L; Rosenbaum JF
    J Clin Psychopharmacol; 2002 Aug; 22(4):379-87. PubMed ID: 12172337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment strategies in patients with major depression not responding to first-line sertraline treatment. A randomised study of extended duration of treatment, dose increase or mianserin augmentation.
    Licht RW; Qvitzau S
    Psychopharmacology (Berl); 2002 May; 161(2):143-51. PubMed ID: 11981594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative effects of mirtazapine and fluoxetine on sleep physiology measures in patients with major depression and insomnia.
    Winokur A; DeMartinis NA; McNally DP; Gary EM; Cormier JL; Gary KA
    J Clin Psychiatry; 2003 Oct; 64(10):1224-9. PubMed ID: 14658972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pindolol and mianserin augment the antidepressant activity of fluoxetine in hospitalized major depressed patients, including those with treatment resistance.
    Maes M; Libbrecht I; van Hunsel F; Campens D; Meltzer HY
    J Clin Psychopharmacol; 1999 Apr; 19(2):177-82. PubMed ID: 10211920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized double-blind comparison of fluoxetine augmentation by high and low dosage folic acid in patients with depressive episodes.
    Venkatasubramanian R; Kumar CN; Pandey RS
    J Affect Disord; 2013 Sep; 150(2):644-8. PubMed ID: 23507369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized, double-blind, and placebo-controlled trial of quetiapine augmentation of fluoxetine in major depressive disorder.
    Garakani A; Martinez JM; Marcus S; Weaver J; Rickels K; Fava M; Hirschowitz J
    Int Clin Psychopharmacol; 2008 Sep; 23(5):269-75. PubMed ID: 18703936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluoxetine treatment of depressed patients with comorbid anxiety disorders.
    Sonawalla SB; Farabaugh A; Johnson MW; Morray M; Delgado ML; Pingol MG; Rosenbaum JF; Fava M
    J Psychopharmacol; 2002 Sep; 16(3):215-9. PubMed ID: 12236627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of mirtazapine and fluoxetine in the treatment of major depressive disorder: a double-blind, randomized trial.
    Amini H; Aghayan S; Jalili SA; Akhondzadeh S; Yahyazadeh O; Pakravan-Nejad M
    J Clin Pharm Ther; 2005 Apr; 30(2):133-8. PubMed ID: 15811165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Olanzapine/fluoxetine combination for the treatment of mixed depression in bipolar I disorder: a post hoc analysis.
    Benazzi F; Berk M; Frye MA; Wang W; Barraco A; Tohen M
    J Clin Psychiatry; 2009 Oct; 70(10):1424-31. PubMed ID: 19906346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Double-blind study of mianserin and fluoxetine in ambulatory therapy of depressed patients].
    Besançon G; Cousin R; Guitton B; Lavergne F
    Encephale; 1993; 19(4):341-5. PubMed ID: 8275922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological treatment of depression in cancer patients. A placebo-controlled study of mianserin.
    van Heeringen K; Zivkov M
    Br J Psychiatry; 1996 Oct; 169(4):440-3. PubMed ID: 8894194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparative clinical trial of fluoxetine, mianserin and placebo in depressed outpatients.
    Muijen M; Roy D; Silverstone T; Mehmet A; Christie M
    Acta Psychiatr Scand; 1988 Sep; 78(3):384-90. PubMed ID: 3057817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of Bright Light Treatment, Fluoxetine, and the Combination in Patients With Nonseasonal Major Depressive Disorder: A Randomized Clinical Trial.
    Lam RW; Levitt AJ; Levitan RD; Michalak EE; Cheung AH; Morehouse R; Ramasubbu R; Yatham LN; Tam EM
    JAMA Psychiatry; 2016 Jan; 73(1):56-63. PubMed ID: 26580307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mirtazapine and paroxetine in major depression: a comparison of monotherapy versus their combination from treatment initiation.
    Blier P; Gobbi G; Turcotte JE; de Montigny C; Boucher N; Hébert C; Debonnel G
    Eur Neuropsychopharmacol; 2009 Jul; 19(7):457-65. PubMed ID: 19345072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Double-blind randomized parallel-group clinical trial of efficacy of the combination fluoxetine plus modafinil versus fluoxetine plus placebo in the treatment of major depression.
    Abolfazli R; Hosseini M; Ghanizadeh A; Ghaleiha A; Tabrizi M; Raznahan M; Golalizadeh M; Akhondzadeh S
    Depress Anxiety; 2011 Apr; 28(4):297-302. PubMed ID: 21456039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomised, double-blind comparison of the efficacy and safety of citalopram compared to mianserin in elderly, depressed patients with or without mild to moderate dementia.
    Karlsson I; Godderis J; Augusto De Mendonça Lima C; Nygaard H; Simányi M; Taal M; Eglin M
    Int J Geriatr Psychiatry; 2000 Apr; 15(4):295-305. PubMed ID: 10767728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.